740
Views
32
CrossRef citations to date
0
Altmetric
Original

INTERLEUKIN-6 GENE EXPRESSION IN PERIPHERAL BLOOD MONONUCLEAR CELLS FROM PATIENTS UNDERGOING HEMODIALYSIS OR CONTINUOUS AMBULATORY PERITONEAL DIALYSIS

, MD, , MD, , MD, , MD & , MD
Pages 345-354 | Published online: 07 Jul 2009

REFERENCES

  • Le J M, Vilcek J. Interleukin 6: a multifunctional cytokine that regulates immune reactions and the acute phase protein response. Lab Invest 1989; 61: 588–602
  • Dinarello C A. Interleukin-1 and the pathogenesis of the acute phase response. N Engl J Med 1984; 311: 1413–1418
  • Shaldon S, Lonnemann G, Koch K M. Cytokine relevance in biocompatibility. Contrib Nephrol 1989; 79: 227–236
  • Chatenoud L, Herbelin A, Beaurain G, Dechamps-Latscha B. Immune deficiency of uremic patients. Adv Nephrol 1990; 19: 259–274
  • Pertosa G, Gesualdo L, Tarantino E A, Ranieri E, Bottalico D, Schena F P. Influence of hemodialysis on interleukin-6 production and gene expression by peripheral blood mononuclear cells. Kidney Int 1993; 43(39)149–153
  • Herbelin A, Nguyen A T, Zingraff J, Urena P, Deschamps-Latscha B. Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor. Kidney Int 1990; 37: 116–125
  • Arden L A, De Groot E R, Schapp O L, Lansdorp P M. Production of hybridoma growth factor by human monocytes. Eur J Immunol 1987; 17: 1411–1416
  • Kimmel P L, Phillips T M, Phillips E, Bosch J P. Effect of renal replacement therapy on cellular cytokine production in patient with renal disease. Kidney Int 1990; 38: 129–135
  • Memoli B, Libetta C, Rampino T, De-Simone W, Meccariello S. Interleukin-6 production of uremic hemodialyzed patients: Effects of different membranes. Nephrol Dial Transplant Suppl 1991; 2: 96–98
  • Luger A, Kovarik J, Stummvoll H K, Urbanska A, Luger T A. Blood-membrane interaction in hemodialysis leads to increased cytokine production. Kidney Int 1987; 32: 84–88
  • Herbelin A, Urena P, Nguyen A T, Zingraff J, Descamps-Latscha B. Elevated circulating levels of interleukin-6 in patients with chronic renal failure. Kidney Int 1991; 39: 954–960
  • Tomino Y, Funabiki K, Ohmuro H, Shimizu M, Yokoyama K, Schirato I, Shirai T, Takahashi M, Koide H. Urinary levels of interleukin 6 and disease activity in patients with IgA nephropathy. Am J Nephrol 1991; 11: 459–464
  • Nakamura T, Ebihara I, Takahashi T, Yamamoto M, Tomino Y, Koide H. Increased Interleukin 6 mRNA expression by peripheral blood T cells from patients with IgA nephropathy. Autoimmunity 1993; 15: 171–179
  • Boyum A. Separation of leukocytes from blood and bone marrow. Scand Clin Lab Invest 1969; 21: 97–105
  • Sambrook J, Fritsh E F, Maniatis T. Molecular Cloning, A Laboratory Manual. Cold Spring Harbor Laboratory. 2, Cold Spring Harbor, New York 1989; 7.3–7.5
  • Feinberg A P, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983; 132: 6–13
  • Church G M, Gilbert W. Genomic sequencing. Proc Natl Acad Sci USA 1991–1995, 1984; 81
  • Ebihara I, Killen P D, Laurie G W, Huang T, Yamada Y, Martin G R, Brown K S. Altered mRNA expression of basement membrane components in a murine model of polycystic kidney disease. Lab Invest 1988; 58: 262–269
  • Cavaillon J M, Poignet J L, Fitting C, Delons S. Serum interleukin-6 in long-term hemodialyzed patient. Nephron 1992; 60: 307–313
  • Anderson J, Briefel G, Jones J M, Ryu J H, McGuire M, Yun Y P. Effects of acetate dialysate on transforming growth factor-b1, interleukin, and α2-microglobulin plasma levels. Kidney Int 1991; 40: 1110–1117
  • Nakahama H, Tanaka Y, Shirai D, Miyazaki M, Imai N, Yokokawa T, Okada M, Kubori S. Plasma interleukin-6 levels in continuous ambulatory peritoneal dialysis and hemodialysis patients. Nephron 1992; 61: 132–134
  • Goldman M, Vandenabeele P, Moulart J, Amraoui Z, Abramowicz D, Nortier J, Vanherwegham J L, Fiers W. Intraperitoneal secretion of interleukin-6 during continuous ambulatory peritoneal dialysis. Nephron 1990; 56: 277–280
  • Matsuda T, Hirano T, Nagasawa S, Kishimoto T. Identification of α2-macroglobulin as a carrier protein for IL-6. J Immunol 1989; 142: 148–152
  • Castell J V, Geiger T, Gross V, Andus T, Walter E, Hirano T, Kishimoto T, Heinricu P C. Plasma clearance, organ distribution and target cells of the rat. Eur J Biochem 1988; 177: 357–361
  • Sedlacek P L, Sunder-Plassmann G, Klaar U, Swoboda K, Derfler K, Kovarik J. Haemodialysis and anti IL-6 autoantibodies. Nephrol Dial Transplant 1992; 7: 739
  • Eisenberg S P, Evans R J, Arend W P, Verderber E, Brewer M T, Hannum C H, Thompson R C. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature(Lond) 1990; 343: 341–346
  • Engelmann H, Novick D, Wallach D. Two tumor necrosis factor-binding proteins purified from human urine. J Biol Chem 1990; 265: 1531–1536
  • Novick D, Engelmann H, Wallach D, Rubinstein M. Soluble cytokine receptors are present in normal human urine. J Exp Med 1989; 170: 1409–1410

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.